Related Experiment Video
Updated: Aug 9, 2026

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
Published on: April 8, 2013
Myocardial revascularization as a therapeutic strategy in the patient with advanced ventricular dysfunction
F A Mitropoulos1, J A Elefteriades
1Section of Cardiothoracic Surgery, Yale University School of Medicine, New Haven, Connecticut 06520-8039, USA.
Insights
Coronary artery bypass grafting (CABG) offers improved quality of life and survival for patients with severe ventricular dysfunction due to coronary artery disease. Careful patient selection and management are key to successful surgical revascularization outcomes.
Area of Science:
- Cardiology
- Cardiac Surgery
- Vascular Surgery
Background:
- Increasing prevalence of severe ventricular dysfunction in coronary artery disease patients.
- Limitations of medical management (ACE inhibitors, beta-blockers) despite favorable impacts.
- Historical reliance on heart transplantation for advanced cases.
Purpose of the Study:
- To review the utility of surgical revascularization in patients with low ejection fraction.
- To discuss patient selection, perioperative management, and long-term outcomes of CABG.
- To highlight CABG as a viable option despite advanced left ventricular dysfunction.
Main Methods:
- Review of clinical experience and pertinent literature.
- Focus on patient selection criteria for coronary artery bypass grafting (CABG).
- Analysis of perioperative management strategies and long-term outcomes.
Main Results:
- CABG can be performed safely in patients with advanced left ventricular dysfunction.
- Significant improvements in quality of life, including angina elimination and enhanced functional capacity.
- Objective demonstration of improved ejection fraction and increased survival post-CABG.
Conclusions:
- Surgical revascularization via CABG is a beneficial option for selected patients with severe ventricular dysfunction.
- Heart transplantation remains indicated for specific complex cases (e.g., right ventricular dysfunction, pulmonary hypertension).
- Optimal patient selection and perioperative care are crucial for maximizing benefits of CABG.
Abstract:
The number of patients with severe ventricular dysfunction from coronary artery disease is constantly increasing. Although the medical management of these patients with angiotensin-converting enzyme inhibitors and beta-blockers has favorable impact on the morbidity and mortality the overall prognosis is still poor. Historically many of these patients have been referred for transplantation. In the past few years there has been an increasing amount of information about the utility of surgical revascularization in patients with low ejection fraction. Careful patient selection and optimal perioperative management is of critical importance for good outcome. Coronary artery bypass grafting (CABG) can be performed relatively safely despite the advanced level of left ventricular dysfunction. Quality of life is improved by CABG with elimination of angina and enhanced functional capacity. Improvement in the ejection fraction and increased survival after the operation has been objectively demonstrated. However patients with advanced right ventricular dysfunction, pulmonary hypertension, redo bypass and ungraftable coronaries should be considered for heart transplantation. In this review we describe our experience and focus on pertinent issues in patient selection, perioperative management and long term outcome after coronary artery bypass grafting.
More Related Videos
09:11Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
Published on: September 22, 2014
07:50Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
Related Concept Videos
Myocarditis III: Medical Management
Coronary Artery Disease V: Interprofessional Care
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care